◀ Back to VEGFA

TGFB3 — VEGFA

Text-mined interactions from Literome

Saadeh et al., Endocrinology 2000 : Similarly, both TGFbeta2 and TGFbeta3 dose dependently increased VEGF protein production
Zheng et al., Am J Physiol Heart Circ Physiol 2001 : Myocyte transforming growth factor-beta [ corrected ] ( TGF-beta ) increased 2.5-fold after 1 h of stretch, and the addition of TGF-beta neutralizing antibodies inhibited the stretch induced upregulation of VEGF
Yamamoto et al., J Cell Biochem 2001 : Although it is known that transforming growth factor ( TGF ) -beta induces vascular endothelial growth factor ( VEGF ) synthesis in vascular smooth muscle cells, the underlying mechanisms are still poorly understood
Bassus et al., Arterioscler Thromb Vasc Biol 2001 (Arterial Occlusive Diseases) : alpha-Thrombin induced VEGF release was significantly reduced by a platelet derived growth factor ( PDGF ) -, a transforming growth factor ( TGF ) -beta- , and a basic fibroblast growth factor (bFGF) neutralizing antibody
Cho et al., Arthritis Rheum 2002 : CSA dose-dependently inhibited both constitutive and transforming growth factor beta induced VEGF production at the protein and mRNA levels
Pawankar et al., Current opinion in allergy and clinical immunology 2003 (Hypersensitivity...) : Increased expression of vascular endothelial growth factor and its upregulation by transforming growth factor-beta can contribute to the edema and increased angiogenesis in nasal polyps
Darland et al., Dev Biol 2003 : Increased VEGF expression was dependent on contact between EC-10T1/2 and was mediated by transforming growth factorbeta ( TGFbeta )
Minami et al., J Biol Chem 2004 : Taken together, the present study provides evidence for a novel association between Hex and GATA and suggests that transforming growth factor beta mediated repression of flk-1/KDR and vascular endothelial growth factor signaling involves the inducible formation of inhibitory Hex-GATA complexes
Youn et al., Immunol Lett 2005 (Arthritis, Rheumatoid...) : In the present study, whether DFU, a tetrasubstituted furanone initially identified as a selective inhibitor of cyclooxygenase (COX)-2, interferes with transforming growth factor ( TGF ) -beta mediated induction of VEGF was determined
Szeto et al., Nephron. Experimental nephrology 2005 : Differential effects of transforming growth factor-beta on the synthesis of connective tissue growth factor and vascular endothelial growth factor by peritoneal mesothelial cell
Kanno et al., Horm Metab Res 2005 (MAP Kinase Signaling System) : SAPK/JNK plays a role in transforming growth factor-beta induced VEGF synthesis in osteoblasts
Stocks et al., FEBS Lett 2005 : Here, we report that vascular endothelial growth factor ( VEGF ) -A secretion by human airway smooth muscle cells was increased by interleukin 1 beta (IL-1beta) and transforming growth factor beta ( TGFbeta )
Burgess et al., Am J Physiol Lung Cell Mol Physiol 2006 (Asthma) : Our aim in this study was to examine the effect of transforming growth factor-beta on the release of connective tissue growth factor and vascular endothelial growth factor from human airway smooth muscle cells derived from asthmatic and nonasthmatic patients
Tanabe et al., J Cell Biochem 2006 : We previously reported that transforming growth factor-beta ( TGF-beta ) stimulates the release of vascular endothelial growth factor ( VEGF ) from aortic smooth muscle A10 cells via activation of p38 mitogen activated protein ( MAP ) kinase
Kuno et al., Biochem Pharmacol 2009 : We have previously reported that transforming growth factor-beta ( TGF-beta ) stimulates the synthesis of vascular endothelial growth factor ( VEGF ) through p44/p42 mitogen activated protein ( MAP ) kinase, p38 MAP kinase and stress activated protein kinase/c-Jun N-terminal kinase ( SAPK/JNK ) in osteoblast-like MC3T3-E1 cells
Shin et al., Respirology 2009 : The effect of transforming growth factor ( TGF ) -beta on the proliferation of ASM cells, the release of vascular endothelial growth factor ( VEGF ) by ASM cells and relevant signal transduction pathways were investigated
Chew et al., BMC cancer 2010 (Nasopharyngeal Neoplasms...) : The present study examined the roles of EBV latent membrane protein-1 (LMP1), interleukin-6 (IL-6), interleukin-10 (IL-10), transforming growth factor-beta 1 ( TGF-ß1 ) and laminin in the regulation of matrix-metalloproteinases ( MMPs ) and vascular endothelial growth factor ( VEGF ) in NPC
Kvanta et al., Curr Eye Res 1995 : Both interleukin-1 and transforming growth factor beta induced VEGF expression in choroidal fibroblasts although with different time courses
Howdieshell et al., Ann Surg 1998 : A factor other than hypoxia, perhaps the earlier appearance of another growth factor, transforming growth factor beta-1 , may positively regulate VEGF appearance in the wound fluid